Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

OM:SAAB B
OM:SAAB BAerospace & Defense

Saab (OM:SAAB B) Valuation Check After New SEK 2.6b Counter Drone Defence Order

Order highlights Saab’s role in drone defence and investor interest Saab (OM:SAAB B) is in focus after securing a SEK 2.6b order from the Swedish Defence Materiel Administration for a mobile, modular counter unmanned aerial system to protect military and civil infrastructure from drones. See our latest analysis for Saab. Despite a 3.2% one day share price decline to SEK642.0, Saab’s 90 day share price return of 14.68% and very large 5 year total shareholder return suggest momentum has been...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

JetBlue’s Fee Hikes and Sale Talks Might Change The Case For Investing In JetBlue Airways (JBLU)

Recently, JetBlue announced past and upcoming changes including higher checked baggage fees tied to rising jet fuel costs, expanded service and added frequencies at Fort Lauderdale-Hollywood International Airport, and enhancements to its TrueBlue loyalty program such as subscriptions and broader points redemption options. At the same time, reports that JetBlue is exploring a potential sale while pressing ahead with its JetForward turnaround plan highlight how the airline is trying to balance...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Why Ultragenyx Pharmaceutical (RARE) Is Up 12.2% After FDA Accepts UX111 Gene Therapy BLA Review

Ultragenyx Pharmaceutical recently announced that the FDA accepted for review its resubmitted BLA for UX111, an AAV9 gene therapy for Sanfilippo syndrome Type A, setting a PDUFA action date of September 19, 2026 and acknowledging robust long-term neurodevelopmental and biomarker data with an acceptable safety profile. This progress, alongside FDA clearance of the IND for UX016 in GNE myopathy, highlights Ultragenyx’s deepening focus on late-stage gene and rare disease therapies backed by...
SEHK:2382
SEHK:2382Electronic

Sunny Optical Technology Group SEHK 2382 Valuation After Earnings Growth Dividend Hike And AR AI Expansion Plans

Sunny Optical Technology (Group) (SEHK:2382) has drawn fresh attention after reporting higher 2025 revenue and net profit, alongside a proposed dividend increase and plans to spin off its vehicle unit and expand AR/AI hardware. See our latest analysis for Sunny Optical Technology (Group). The earnings and dividend news comes after a sharp rebound in recent days, with a 1 week share price return of 13.34% and 1 month share price return of 12.49%. However, the year to date share price return of...
NYSE:HNGE
NYSE:HNGEHealthcare

Hinge Health Public Sector Expansion Meets Discounted Valuation And Weak Momentum

Hinge Health (NYSE:HNGE) is extending its musculoskeletal care platform to cover more than 5 million public sector employees across the US. The expansion includes 24 state employee health plan clients and a range of public institutions spanning state and local governments and higher education. This rollout broadens Hinge Health's reach to public sector populations in all 50 states. For investors watching NYSE:HNGE, this public sector expansion comes as the stock trades at $38.98, with...
NYSE:UHAL
NYSE:UHALTransportation

U-Haul Opens Rossford Site As Investors Weigh Valuation And Earnings Trends

U-Haul Holding (NYSE:UHAL) has opened its first company-owned retail, moving, and storage facility in Rossford, Ohio. The new site expands U-Haul's physical presence and services in Northwest Ohio, bringing additional storage capacity and rental options to local residents. The facility is expected to create local jobs and increase access to moving solutions for households and businesses in a previously unserved area. U-Haul Holding, trading at around $47.29 per share, is adding bricks and...
NasdaqGS:LKFN
NasdaqGS:LKFNBanks

Lakeland Financial (LKFN) Valuation Check After Recent Mixed Share Price Performance

Lakeland Financial: recent performance catches investor attention Lakeland Financial (LKFN) is back on some investors’ radars after a mixed run in the share price, with a small gain over the past 3 months following a modest pullback over the past month. See our latest analysis for Lakeland Financial. At around $58.12 per share, Lakeland Financial’s recent 7 day share price return of 2.04% contrasts with a softer 30 day move, while the 1 year total shareholder return of 7.92% points to...
SEHK:1288
SEHK:1288Banks

Assessing Agricultural Bank of China’s Valuation After Full-Year 2025 Earnings Lift Investor Sentiment

Agricultural Bank of China (SEHK:1288) drew attention after announcing its full year 2025 results, with net income and earnings per share above the prior year while net interest income softened slightly. See our latest analysis for Agricultural Bank of China. The earnings release appears to have lifted sentiment, with the share price at HK$5.68 and a 7 day share price return of 6.17% and 30 day share price return of 8.40%. However, the 90 day share price return is a 2.57% decline; over the...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

Is DexCom (DXCM) Fairly Priced After Recent Share Price Weakness?

This article examines whether DexCom is fairly priced at current levels by focusing on what investors receive for the price they pay. DexCom's share price recently closed at US$62.22, reflecting returns of a 5.9% decline over 7 days, a 14.9% decline over 30 days, a 6.5% decline year to date, a 0.7% change over 1 year, a 44.7% decline over 3 years and a 34.2% decline over 5 years, which provides important context for any valuation view. Recent news coverage has centered on DexCom's role in...
NYSE:COHR
NYSE:COHRElectronic

Coherent (COHR) Is Up 6.1% After Expanded Nvidia Deal And AI Datacenter Optics Breakthrough - What's Changed

In recent weeks, Coherent Corp. has expanded its AI datacenter footprint through a 400 Gbps silicon photonics breakthrough with Tower Semiconductor, unveiled at OFC, while also preparing technical presentations at ICDT 2026 in Chongqing and SEMICON China 2026 in Shanghai. At the same time, Coherent’s index inclusion and enlarged, multi‑billion‑dollar supply relationship with Nvidia are reshaping its role in next‑generation AI infrastructure and datacenter optics. Now we’ll explore how the...
OM:ERIC B
OM:ERIC BCommunications

Ericsson Shares Rally As Vonage Broot.ai Deal Extends Enterprise Reach

Ericsson's Vonage unit has partnered with India based AI startup Broot.ai to enable real time, in app global calling for enterprise sales and marketing teams. The service is powered by Vonage Voice APIs and is aimed at businesses that want integrated calling inside their customer engagement platforms. The move reflects Ericsson's push to broaden its communication services beyond traditional telecom through AI powered, cloud based offerings. For investors tracking Telefonaktiebolaget LM...
ASX:TLS
ASX:TLSTelecom

How Telstra’s Large On‑Market Share Buy‑Back Will Impact Telstra Group (ASX:TLS) Investors

In recent days, Telstra Group Limited notified the ASX that its ongoing on-market share buy-back has reached a cumulative 158,604,923 ordinary shares, including 2,124,763 shares repurchased on the immediately preceding trading day. This sizable and continuing buy-back effort highlights Telstra’s active capital management approach, which can influence earnings per share and signal balance sheet strength to investors. We’ll now examine how Telstra’s continued on-market share buy-back program...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Should Court Rebuke of HISA Fees Reshape Churchill Downs’ (CHDN) Regulatory Risk Calculus?

In March 2026, Churchill Downs Incorporated announced that a U.S. District Court in Kentucky ruled the Horseracing Integrity and Safety Authority’s purse‑weighted fee methodology and related fee collection efforts unlawful, calling them arbitrary and capricious. By underscoring what its CEO describes as regulatory overreach and fiscal mismanagement at HISA, the ruling could reshape Churchill Downs’ compliance costs and its role in U.S. horseracing governance. Next, we’ll examine how this...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

Is It Time To Reassess T-Mobile US (TMUS) After Its Recent Share Price Slide

If you are wondering whether T-Mobile US at around US$201.40 is pricing in too much optimism or not enough, the current numbers offer a useful starting point for that question. The stock is roughly flat year to date with a 0.9% return. However, that sits alongside a 7.8% decline over 30 days, a 4.8% decline over 7 days, and a 23.5% decline over the past year, even after 3-year and 5-year returns of 40.0% and 61.0%. Recent headlines have focused on T-Mobile US as a major US wireless carrier,...
ASX:ALL
ASX:ALLHospitality

How Aristocrat’s On‑Market Buy‑Back Progress Will Impact Aristocrat Leisure (ASX:ALL) Investors

Aristocrat Leisure recently reported that its ongoing on-market share buy-back has retired more than 22 million ordinary shares to date, highlighting continued execution of its capital management plan. By steadily reducing its share count through these past repurchases, the company is aiming to improve capital efficiency and potentially strengthen earnings metrics for remaining shareholders. Next, we’ll examine how Aristocrat’s sizeable on-market buy-back progress could influence its...
NYSE:UE
NYSE:UERetail REITs

A Look At Urban Edge Properties (UE) Valuation As Shares Trade Near Estimated Fair Value

Why Urban Edge Properties is on investors’ radar today Urban Edge Properties (UE) continues to trade around recent levels, with shares closing at US$20.37. This keeps the US$2.64b retail REIT in focus for investors watching income oriented real estate names. See our latest analysis for Urban Edge Properties. Recent trading has been mixed, with a 2.41% 1 day share price return and a 6.65% year to date share price return set against a 2.81% 1 month pullback. At the same time, the 1 year total...
NYSE:BLSH
NYSE:BLSHCapital Markets

A Look At Bullish (BLSH) Valuation As Shares Trade At A High Price To Sales Multiple

Bullish (BLSH) has drawn fresh attention after recent price moves, with a 3.7% gain over the past day and just under 10% over the past month, despite weaker performance across the past 3 months. See our latest analysis for Bullish. With the share price at $36.37, Bullish shows mixed momentum, with a 1 month share price return of 9.8% alongside a 90 day share price return decline of 7.4%, suggesting interest has picked up recently after earlier weakness. If you are looking beyond Bullish to...
NYSE:ZTO
NYSE:ZTOLogistics

How ZTO Express (Cayman)'s New US$1.50 Billion Buyback Plan (ZTO) Has Changed Its Investment Story

In its recently reported 2025 results, ZTO Express (Cayman) highlighted strong parcel volume growth, market share gains, and technology-driven efficiency improvements, while authorizing a US$1.50 billion share repurchase program and pledging to return at least half of adjusted earnings to shareholders. An interesting takeaway is that ZTO is pairing its operational expansion with sizable shareholder returns, signaling confidence in cash generation despite rising costs and some margin...
NYSE:CXW
NYSE:CXWCommercial Services

A Look At CoreCivic (CXW) Valuation As Insider Selling And ICE Policy Shifts Draw Attention

Insider selling and policy shifts put CoreCivic (CXW) in focus CoreCivic (CXW) is drawing attention after Chief Administrative Officer Cole Carter sold 12,500 shares under a pre arranged plan, alongside news that ICE intends to scale back privately operated detention facilities. See our latest analysis for CoreCivic. CoreCivic’s recent 1 day share price return of 7.21% to US$20.51 follows a 30 day share price return of 11.83% and a 3 year total shareholder return of about 120%. This suggests...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Is It Too Late To Consider Pulse Biosciences (PLSE) After Recent Share Price Surge?

Investors may be wondering whether Pulse Biosciences, at around US$23 per share, still offers value or whether most of the opportunity is already reflected in the price. The stock shows returns of 7.0% over 7 days, 28.1% over 30 days, 71.8% year to date and 58.3% over 1 year. These figures naturally raise questions about what is already priced in and how much risk you are taking on at current levels. Recent attention on Pulse Biosciences has centered on its position in the medical equipment...
NYSE:SO
NYSE:SOElectric Utilities

Does Georgia Power’s New Battery Buildout Reshape the Bull Case for Southern (SO)?

Southern subsidiary Georgia Power recently began construction on a 260 MW battery energy storage system in Jefferson County, Georgia, and is planning two additional solar-plus-storage projects totaling 350 MW to support rising renewable demand. This build-out of utility-scale storage and paired solar marks a meaningful shift in Southern’s grid capabilities, potentially enhancing reliability and supporting cleaner energy integration across its regulated footprint. We’ll now explore how...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

Interactive Brokers March Records Highlight Crypto Expansion And Valuation Debate

Interactive Brokers Group reported record March figures, with daily average revenue trades up 25% year over year. Client accounts reached a new high in March, rising 31% compared with the same month a year earlier. The surge in activity follows the firm’s European rollout of integrated crypto trading and expanded digital asset support. For investors watching NasdaqGS:IBKR, the latest operating data adds context to a share price of $67.74 and a 70.8% return over the past year. Over 3 years...
NYSE:GIC
NYSE:GICTrade Distributors

A Look At Global Industrial (GIC) Valuation After Quarterly Revenue Tops Expectations

Global Industrial (GIC) drew attention after quarterly revenue rose 14.3% year on year and came in 6.4% above consensus, even as EBITDA lagged forecasts. This highlighted a split between sales momentum and profitability. See our latest analysis for Global Industrial. The share price is at $31.37 after a recent 6.6% 90 day share price return, while the 1 year total shareholder return of 49.2% points to strong longer term momentum despite a softer 30 day move. If strong revenue trends have you...
NasdaqGS:CAR
NasdaqGS:CARTransportation

A Look At Avis Budget Group (CAR) Valuation As New Share Offering Raises Dilution Concerns

Avis Budget Group (CAR) is under the spotlight after filing to sell up to 5 million new common shares, a move that has raised dilution concerns and immediately weighed on recent stock sentiment. See our latest analysis for Avis Budget Group. Despite the dilution headlines, short term momentum has been strong, with a 1 month share price return of 96.35% and a year to date share price return of 48.51%, while the 1 year total shareholder return sits at 162.25%. If you are looking beyond car...